{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T15:00:35Z","timestamp":1786546835497,"version":"build-2736575974"},"reference-count":12,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T00:00:00Z","timestamp":1786492800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T00:00:00Z","timestamp":1786492800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100009337","name":"Saitama Medical University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100009337","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["CEN Case Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Lysozyme-induced nephropathy (LyN) is a rare kidney complication associated with chronic myelomonocytic leukemia (CMML). This condition is characterized by distinctive pathological features, including granules within proximal tubular cells that stain positively with periodic acid-Schiff or lysozyme staining, and granular deposits identified as high-electron-density deposits under electron microscopy. Although CMML is the most common cause of LyN, previous reports have suggested that its occurrence may be associated with the myelodysplastic syndrome (MDS). This report describes cases of LyN in a patient with MDS and CMML. Although both the LyN cases, caused by either MDS or CMML, exhibited similar kidney pathological findings, there was a clinical difference in the occurrence of peripheral blood monocytosis. The MDS-induced LyN showed no persistent peripheral blood monocytosis and, when the bone marrow biopsy specimens were stained with lysozyme, numerous positive cells were observed. Thus, hematologic disorders wherein the bone marrow comprises lysozyme-producing cells may induce LyN, even without peripheral blood monocytosis.<\/jats:p>","DOI":"10.1007\/s13730-026-01170-x","type":"journal-article","created":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T01:51:24Z","timestamp":1786499484000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Two cases of lysozyme-induced nephropathy with varying underlying diseases: myelodysplastic syndrome and chronic myelomonocytic leukemia"],"prefix":"10.1007","volume":"15","author":[{"given":"Hisashi","family":"Furukawa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsutomu","family":"Inoue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minako","family":"Tanioka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuya","family":"Kusuyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mizuya","family":"Ito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatsuo","family":"Kondo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daichi","family":"Fukaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroaki","family":"Amano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koji","family":"Tomori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusuke","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiromichi","family":"Iwashita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei","family":"Hamada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koji","family":"Okudera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoiku","family":"Takaku","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuichi","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirokazu","family":"Okada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,12]]},"reference":[{"key":"1170_CR1","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/j.ejim.2011.05.005","volume":"22","author":"CF Christiansen","year":"2011","unstructured":"Christiansen CF, Johansen MB, Langeberg WJ, Fryzek JP, S\u00f8rensen HT. Incidence of acute kidney injury in cancer patients: a Danish population-based cohort study. Eur J Intern Med. 2011;22:399\u2013406.","journal-title":"Eur J Intern Med"},{"key":"1170_CR2","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1053\/j.ackd.2013.07.004","volume":"21","author":"RL Luciano","year":"2014","unstructured":"Luciano RL, Brewster UC. Kidney involvement in leukemia and lymphoma. Adv Chronic Kidney Dis. 2014;21:27\u201335.","journal-title":"Adv Chronic Kidney Dis"},{"key":"1170_CR3","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.ekir.2016.09.002","volume":"2","author":"D Santoriello","year":"2017","unstructured":"Santoriello D, Andal LM, Cox R, D\u2019Agati VD, Markowitz GS. Lysozyme-Induced Nephropathy. Kidney Int Rep. 2017;2:84\u20138.","journal-title":"Kidney Int Rep"},{"key":"1170_CR4","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1007\/s13730-020-00567-6","volume":"10","author":"M Asano","year":"2021","unstructured":"Asano M, Hase H, Naruse Y, Kawada K, Kojima I, Branch J, et al. A rare cause of acute kidney injury with chronic myelomonocytic leukemia. CEN Case Rep. 2021;10:320\u20135.","journal-title":"CEN Case Rep"},{"key":"1170_CR5","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1053\/j.ajkd.2008.11.013","volume":"54","author":"TV Patel","year":"2009","unstructured":"Patel TV, Rennke HG, Sloan JM, DeAngelo DJ, Charytan DM. A forgotten cause of kidney injury in chronic myelomonocytic leukemia. Am J Kidney Dis. 2009;54:159\u201364.","journal-title":"Am J Kidney Dis"},{"key":"1170_CR6","doi-asserted-by":"publisher","first-page":"1585","DOI":"10.1016\/j.ekir.2023.05.007","volume":"8","author":"S Kudose","year":"2023","unstructured":"Kudose S, Cossey LN, Canetta PA, Sekulic M, Vanbeek CA, Huls FB, et al. Clinicopathologic spectrum of lysozyme-associated nephropathy. Kidney Int Rep. 2023;8:1585\u201395.","journal-title":"Kidney Int Rep"},{"key":"1170_CR7","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1084\/jem.124.5.921","volume":"124","author":"EF Osserman","year":"1966","unstructured":"Osserman EF, Lawlor DP. Serum and urinary lysozyme (muramidase) in monocytic and monomyelocytic leukemia. J Exp Med. 1966;124:921\u201352.","journal-title":"J Exp Med"},{"key":"1170_CR8","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1038\/ki.1979.32","volume":"15","author":"PD Ottosen","year":"1979","unstructured":"Ottosen PD, Bode F, Madsen KM, Maunsbach AB. Renal handling of lysozyme in the rat. Kidney Int. 1979;15:246\u201354.","journal-title":"Kidney Int"},{"key":"1170_CR9","doi-asserted-by":"publisher","first-page":"1694","DOI":"10.1172\/JCI106387","volume":"49","author":"W Pruzanski","year":"1970","unstructured":"Pruzanski W, Platts ME. Serum and urinary proteins, lysozyme (muramidase), and renal dysfunction in mono- and myelomonocytic leukemia. J Clin Invest. 1970;49:1694\u2013708.","journal-title":"J Clin Invest"},{"key":"1170_CR10","unstructured":"Li W. The 5(th) Edition of the world health organization classification of hematolymphoid tumors. In: Li W, editor. Leukemia. Brisbane (AU): Exon Publications"},{"key":"1170_CR12","first-page":"278","volume":"42","author":"K Okano","year":"1994","unstructured":"Okano K, Yamamoto K, Ueda J, Fujii Y, Yonehara Y, Araki M. The interrelation of serum lysozyme level and cytoplasmic lysozyme level. Rinsho Byori. 1994;42:278\u201382.","journal-title":"Rinsho Byori"},{"key":"1170_CR13","first-page":"1","volume":"9","author":"J Spapen","year":"2016","unstructured":"Spapen J, Fostier K, De Raeve H, Janssens P, Spapen H. An unexpected complication of chronic myelomonocytic leukemia: severe renal failure due to malignant tubulo-interstitial cell infiltration. Int J Nephrol Renovasc Dis. 2016;9:1\u20134.","journal-title":"Int J Nephrol Renovasc Dis"}],"container-title":["CEN Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13730-026-01170-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13730-026-01170-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13730-026-01170-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T14:03:27Z","timestamp":1786543407000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13730-026-01170-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,12]]},"references-count":12,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2026,10]]}},"alternative-id":["1170"],"URL":"https:\/\/doi.org\/10.1007\/s13730-026-01170-x","relation":{},"ISSN":["2192-4449"],"issn-type":[{"value":"2192-4449","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,12]]},"assertion":[{"value":"9 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors have declared that no Conflict of interest exists.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures involving human participants were in accordance with the principles evinced in the Declaration of Helsinki, 1964, and its later amendments or comparable ethical standards.","order":2,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Informed consent was obtained from all study participants.","order":3,"name":"Ethics","label":"Informed consent","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"133"}}